Heparin-containing adhesion prevention barrier and process
AssigneeJohnson & Johnson Patient Care, Inc.
InventorsGary Linsky, Timothy Cunningham, Eli Pines
Life of this patent
Estimating the term…
Abstract
An improved adhesion-preventative barrier fabric comprising an oxidized regenerated cellulose (ORC) fabric (or matrix having equivalent properties) which is drapable, conformable, adherent to body organs. and substantially absorbable within thirty (30) days in the body, which fabric has heparin absorbed thereon, said heparin being present in a non-toxic, adhesion-preventative, effective amount and potency; and, the process of using said improved barrier fabric or matrix to administer heparin to prevent surgical adhesions.
Claims18
An improved adhesion-preventative barrier fabric comprising an oxidized regenerated cellulose fabric which is drapable, conformable, adherent to body organs, and substantially absorbable within thirty (30) days in the body, which fabric has heparin absorbed thereon, said heparin being present in a non-toxic, adhesion-preventative effective amount and potency.
The process of administering heparin topically to an internal body organ during surgery for the purpose of preventing surgical adhesions which comprises:
- applying an oxidized regenerated cellulose fabric containing heparin absorbed on it to the outer surface of an internal body organ, said fabric being drapable, conformable, adherent to body organs, and substantially absorbable within thirty (30) days in the body.
An improved adhesion-preventative barrier material comprising a matrix which is safe for use in surgery and is drapable, conformable, adherent to body organs, and substantially absorbable within thirty (30) days in the body, which matrix has heparin absorbed thereon, said heparin being present in a non-toxic, adhesion-preventative effective amount and potency.
Dependencies are inferred from the claim text.